Concentration Details

Metabolite
HMDB0000333 (Isohomovanillic acid)
Biospecimen
Urine
Status
Detected but not Quantified
Data source
Referenced
Concentration
Not Quantified
Age
Not Specified
Sex
Not Specified
Condition
Parkinson's Disease
Comments
Patients with Parkinson's disease were either treated with (1) L-DOPA or (2) L-DOPA and an inhibitor of DOPA-decarboxylase.
References
    1. Ebinger G, Adriaenssens K: Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease. Clin Chim Acta. 1973 Nov 15;48(4):427-31. [PubMed:4761590 ]